In the past decade, new oral anticoagulants (NOACs) have transformed the prophylaxis and treatment of thromboembolism. However, few data are available on the reversal of NOACs. Clinicians may face challenges when patients using NOACs present with bleeding complications or prior to urgent interventional procedures.

Please join us for the symposium Update in the Reversal of Oral Anticoagulants: New Developments and Clinical Strategies. The symposium will address therapeutic strategies to reverse the anticoagulant state and approaches to the management of patients receiving older and newer anticoagulants. This valuable information for clinicians will be presented by an expert faculty panel, including the chairperson, Sam Schulman, MD, FRCPC(C), current president of ISTH. The symposium will be held Wednesday, June 24, 2015, from 12:00 to 13:45 in Room 701, Level 700 of the South Building of the Metro Toronto Convention Centre.

For more information, please go to www.NOACReversal.com.

By |June 23, 2015